Literature DB >> 10362647

Functional characteristics of basolateral peptide transporter in the human intestinal cell line Caco-2.

T Terada1, K Sawada, H Saito, Y Hashimoto, K Inui.   

Abstract

The apical H+-coupled peptide transporter (PEPT1) and basolateral peptide transporter in human intestinal Caco-2 cells were functionally compared by the characterization of [14C]glycylsarcosine transport. The glycylsarcosine uptake via the basolateral peptide transporter was less sensitive to medium pH than uptake via PEPT1 and was not transported against the concentration gradient. Kinetic analysis indicated that glycylsarcosine uptake across the basolateral membranes was apparently mediated by a single peptide transporter. Small peptides and beta-lactam antibiotics inhibited glycylsarcosine uptake by the basolateral peptide transporter, and these inhibitions were revealed to be competitive. Comparison of the inhibition constant values of various beta-lactam antibiotics between PEPT1 and the basolateral peptide transporter suggested that the former had a higher affinity than the latter. A histidine residue modifier, diethyl pyrocarbonate, inhibited glycylsarcosine uptake by both transporters, although the inhibitory effect was greater on PEPT1. These findings suggest that a single facilitative peptide transporter is expressed at the basolateral membranes of Caco-2 cells and that PEPT1 and the basolateral peptide transporter cooperate in the efficient transepithelial transport of small peptides and peptidelike drugs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10362647     DOI: 10.1152/ajpgi.1999.276.6.G1435

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  27 in total

1.  Effects of tacrolimus and cyclosporin A on peptide transporter PEPT1 in Caco-2 cells.

Authors:  H Motohashi; T Katsura; H Saito; K Inui
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

2.  Genomic structure of proton-coupled oligopeptide transporter hPEPT1 and pH-sensing regulatory splice variant.

Authors:  A Urtti; S J Johns; W Sadée
Journal:  AAPS PharmSci       Date:  2001

Review 3.  Small bowel review: Normal physiology, part 1.

Authors:  Alan B R Thomson; Laurie Drozdowski; Claudiu Iordache; Ben K A Thomson; Severine Vermeire; M Tom Clandinin; Gary Wild
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

4.  Prediction of glycylsarcosine transport in Caco-2 cell lines expressing PEPT1 at different levels.

Authors:  Megumi Irie; Tomohiro Terada; Masahiro Tsuda; Toshiya Katsura; Ken-Ichi Inui
Journal:  Pflugers Arch       Date:  2005-11-10       Impact factor: 3.657

5.  Transport characteristics of L-carnosine and the anticancer derivative 4-toluenesulfonylureido-carnosine in a human epithelial cell line.

Authors:  Carsten Uhd Nielsen; Claudiu T Supuran; Andrea Scozzafava; Sven Frokjaer; Bente Steffansen; Birger Brodin
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

Review 6.  Review of Pharmacokinetic Data of Different Drug Classes in Goto-Kakizaki Rats, a Non-obese Model for Type 2 Diabetes Mellitus: Case Studies and Perspectives.

Authors:  Harilal Patel; Poonam Giri; Nuggehally R Srinivas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-04       Impact factor: 2.441

7.  Transport mechanisms of carnosine in SKPT cells: contribution of apical and basolateral membrane transporters.

Authors:  Dilara Jappar; Yongjun Hu; Richard F Keep; David E Smith
Journal:  Pharm Res       Date:  2008-09-27       Impact factor: 4.200

8.  The apical (hPepT1) and basolateral peptide transport systems of Caco-2 cells are regulated by AMP-activated protein kinase.

Authors:  Myrtani Pieri; Helen C Christian; Robert J Wilkins; C A R Boyd; David Meredith
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-04-29       Impact factor: 4.052

9.  Inhibitory effect of zinc on PEPT1-mediated transport of glycylsarcosine and beta-lactam antibiotics in human intestinal cell line Caco-2.

Authors:  Miyako Okamura; Tomohiro Terada; Toshiya Katsura; Hideyuki Saito; Ken-ichi Inui
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

10.  Enhanced cancer cell growth inhibition by dipeptide prodrugs of floxuridine: increased transporter affinity and metabolic stability.

Authors:  Yasuhiro Tsume; John M Hilfinger; Gordon L Amidon
Journal:  Mol Pharm       Date:  2008-07-25       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.